Monoclonal/polyclonal PAX-8, PTH and GATA3 immunohistochemistry in parathyroid lesions
- PMID: 33566340
- DOI: 10.1007/s40618-021-01518-3
Monoclonal/polyclonal PAX-8, PTH and GATA3 immunohistochemistry in parathyroid lesions
Abstract
Background: Parathyroid gland (PG) is an endocrine organ which may display different immunohistochemical stainings with chief cells and oxyphilic cells in normal as well as hyperplasic/tumoral lesions.
Purpose: In this study, we aimed to identify the demographic properties and diagnostic value of the GATA3 antibody, which is a transcription factor in addition to PTH, and of PAX-8 (monoclonal and polyclonal) antibody.
Methods: We have analyzed in detail the cellular components and staining intensities of 46 adenomas all of which contained parathyroid rims, 12 hyperplasia and 5 adjacent non-neoplastic thyroidectomy materials (63 patients, 114 tissues).
Results: While no staining was identified in the thyroid tissue, cytoplasmic PTH immunoreactivity was observed in all (100%) normal parathyroid tissues, rim of PGs and hyperplasia, and in 43/46 cases (93.4%) of adenomas. Adenoma and hyperplasia were less stained than normal PG (p < 0.05). We detected GATA3 staining in all cases except for the thyroid (100%). Weak positivity (1+) was most apparent in adenoma cases (p < 0.05). Monoclonal PAX-8 immunoreactivity was not identified in any normal parathyroid tissue and rim of PG but positive immunoreactivity was detected in 83.3% of hyperplasia cases (10/12), 84.8% of adenoma (39/46) and 100% of thyroid tissues (5/5) (p < 0.05). However, polyclonal PAX-8 immunoreactivity was detected in one normal parathyroid tissue (1/5) and seven (7/46) rim of PGs. In cases of hyperplasia and adenoma, positive immunoreactivity was 75% (9/12) and 74% (34/46), respectively.
Conclusion: In conclusion, we have observed that PTH and GATA3 constitute a much more reliable and sensitive marker for parathyroid and are stained less in adenomas. While monoclonal PAX-8 (MRQ-50) never stains normal parathyroid and rim of PGs, it may help in the differential diagnosis of proliferated parathyroid lesions as a considerably sensitive and relatively specific marker by staining hyperplasic parathyroid, adenomas and the thyroid.
Keywords: GATA3; MRQ-50; Monoclonal/polyclonal antibody; PAX-8; PTH; Parathyroid adenoma/hyperplasia.
© 2021. Italian Society of Endocrinology (SIE).
Similar articles
-
Diagnostic value of GATA-3 in cytological identification of parathyroid tissues.Endocr J. 2016 Jul 30;63(7):621-6. doi: 10.1507/endocrj.EJ15-0700. Epub 2016 Apr 19. Endocr J. 2016. PMID: 27097544
-
Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.Indian J Pathol Microbiol. 2014 Oct-Dec;57(4):549-52. doi: 10.4103/0377-4929.142658. Indian J Pathol Microbiol. 2014. PMID: 25308005
-
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.Virchows Arch A Pathol Anat Histopathol. 1991;418(4):295-9. doi: 10.1007/BF01600157. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 2024450
-
Does Strong and Diffuse PAX-8 Positivity Occur in Primary Lung Carcinoma? An Immunohistochemical Study of 418 Cases and Review of the Literature.Appl Immunohistochem Mol Morphol. 2019 Feb;27(2):140-146. doi: 10.1097/PAI.0000000000000549. Appl Immunohistochem Mol Morphol. 2019. PMID: 28777151 Review.
-
Pax-8: Molecular biology, pathophysiology, and potential pathogenesis.Biofactors. 2024 May-Jun;50(3):408-421. doi: 10.1002/biof.2016. Epub 2023 Nov 21. Biofactors. 2024. PMID: 37988248 Review.
Cited by
-
Overview of the 2022 WHO Classification of Parathyroid Tumors.Endocr Pathol. 2022 Mar;33(1):64-89. doi: 10.1007/s12022-022-09709-1. Epub 2022 Feb 17. Endocr Pathol. 2022. PMID: 35175514 Review.
-
Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.Int J Mol Sci. 2022 Jun 23;23(13):6981. doi: 10.3390/ijms23136981. Int J Mol Sci. 2022. PMID: 35805976 Free PMC article. Review.
-
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entities.Virchows Arch. 2024 Sep;485(3):491-507. doi: 10.1007/s00428-024-03872-y. Epub 2024 Aug 6. Virchows Arch. 2024. PMID: 39105782 Free PMC article.
-
Cytopathology of follicular and oncocytic follicular thyroid neoplasms: A Bethesda System perspective.Cancer Cytopathol. 2025 May;133(5):e70016. doi: 10.1002/cncy.70016. Cancer Cytopathol. 2025. PMID: 40272265 Free PMC article. Review.
-
Top 10 Clear Cell Head and Neck Lesions to Contemplate.Head Neck Pathol. 2023 Mar;17(1):33-52. doi: 10.1007/s12105-022-01518-6. Epub 2023 Mar 16. Head Neck Pathol. 2023. PMID: 36928734 Free PMC article. Review.
References
-
- Lloyd RV (1990) Parathyroid glands. In: Lloyd RV (ed) Endocrine pathology. Springer, New York, pp 71–83 - DOI
-
- Rosai J (2004) Parathyroid glands. In: Rosai J (ed) Rosai and Ackerman’s surgical pathology, 9th edn. Mosby, New York, pp 595–619
-
- Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, Drapkin R, Hirsch MS (2011) A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 35:816–826 - DOI
-
- Ozcan A, Shen SS, Hamilton C et al (2011) PAX 8 expression in nonneoplastic tissues, primary tumors, and metastatic tumors:a comprehensive immunohistochemical study. Mod Pathol 24:751–764 - DOI
-
- Ordonez NG (2012) Value of PAX 8 immunostaining in tumor diagnosis:a review and update. Adv Anat Pathol 19:140–151 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical